Clinical Trials Browser

Phase 1 × ADI PEG20 × Gastrointestinal × Clear all

NCT02101580 2020-10-01

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Advanced Pancreatic Cancer

NCT02029690 2020-09-25

TRAP

Phase 1 Terminated

CNSDermatologicGastrointestinal

Uveal Melanoma, Carcinoma, Glioma, Carcinoma, Hepatocellular

NCT02101593 2016-03-04

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular